Granulocyte colony stimulating factor (Xenetic Biosciences/SynBio)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameGranulocyte colony stimulating factor (Xenetic Biosciences/SynBio)
Drug Alias NamePolysialic G-CSF重组人粒细胞集落刺激因子 - Xenetic Biosciences/SynBioStimuXenSYN-20111504-RU
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionColony stimulating factor 3 receptor agonists
TargetsColony stimulating factor 3 receptor
Therapy Area/IndicationsNeutropenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesLipoxen Technologies LtdSerum Institute Of India Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLipoxen Technologies LtdSynbioXenetic Biosciences Inc +[4] 
Active IndicationsN/A
Inactive IndicationsNeutropenia

Other Information

ATC CodeN/A
Related LinksN/A